S. Drescher et al.
29 –CH2(CH2)11O–), 3.62 (t, 3J = 6.6 Hz, 4H, 29 –(CH2)11
CH2O–), 7.20–7.48 (m, 8H, –C6H4C6H4–) ppm; 13C NMR
(100 MHz, CDCl3, 45 °C): d = 25.74 (–CH2(CH2)2OH),
29.37, 29.54, 29.60, 31.35 (–CH2CH2C6H4C6H4CH2CH2–),
32.81 (–CH2CH2OH), 35.55 (–CH2C6H4C6H4CH2–), 63.05
(–CH2OH), 126.71 (2,20,6,60-C, –C6H4C6H4–), 128.63 (3,30,
5,50-C, –C6H4C6H4–), 138.51 (1,10-C, –C6H4C6H4–), 141.68
(4,40-C, –C6H4C6H4–) ppm; MS (70 eV): m/z (%) = 522
(100) [M?], 504 (5) [M?-H2O].
100 cm3 of a cold saturated solution of NH4Cl. The organic
layer was separated and the aqueous phase was extracted
with 60 cm3 Et2O (29). The combined organic phases
were washed with 50 cm3 brine and 50 cm3 H2O, dried
over Na2SO4 and concentrated to dryness in vacuo. The
residue was purified by column chromatography using the
gradient technique and heptane–Et2O and TEA (0.5 %) as
eluent to afford 0.91 g (25 %) of 9 as white crystalline
substance. Rf = 0.42 (solvent B); 1H NMR (500 MHz,
CDCl3): d = 1.24–1.36 (m, 24H, –(CH2)2(CH2)12-
(CH2)2O–), 1.50–1.89 (m, 10H, –CH2CH2(CH2)12-
CH2CH2O–, –OCH(CH2)3CH2O–), 2.57 (t, 3J = 7.5 Hz,
2H, –CH2C6H4CH2O–), 3.45 (t, 3J = 6.7 Hz, 2H,
–CH2OCH2C6H5), 3.51–3.56 (m, 1H, –OCH(CH2)3-
CH2O–), 3.88–3.94 (m, 1H, –OCH(CH2)3CH2O–), 4.49
(d, 2J = 12.2 Hz, 1H, –CH2C6H4CH2O–), 4.57 (s, 2H,
–OCH2C6H5), 4.68–4.70 (m, 1H, –OCHO–), 4.77 (d,
2J = 12.2 Hz, 1H, –CH2C6H4CH2O–), 7.13–7.15 (m, 2H,
2,6-H –C6H4–), 7.25–7.27 (m, 2H, 3,5-H –C6H4–),
7.32–7.35 (m, 5H, –C6H5) ppm; 13C NMR (125 MHz,
CDCl3): d = 19.32 (CHCH2CH2(CH2)2O–), 25.45
(CH(CH2)2CH2CH2O–), 26.19 (–CH2(CH2)2OCH2C6H5),
29.33, 29.43, 29.51, 29.59, 29.60, 29.65, 29.66, 29.77
(–CH2–), 30.54 (CHCH2(CH2)3O–), 31.51 (–CH2CH2C6
H4CH2O–), 35.69 (–CH2C6H4CH2O–), 62.07 (CH(CH2)3
CH2O–), 68.34 (–C6H4CH2O–), 70.53 (–OCH2C6H5),
72.83 (–CH2OCH2C6H5), 97.78 (–OCHO–), 127.41 (4-C,
–C6H5), 127.58 (2,6-C, –C6H5), 127.89 (2,6-C, –C6H4–),
128.30 and 128.37 (3,5-C, –C6H5 and –C6H4–), 138.70 and
138.73 (1-C, –C6H5 and –C6H4–), 142.28 (4-C, –C6H4–)
ppm; MS (70 eV): m/z (%) = 522 (49) [M?].
General procedure for the preparation
of phenylene-modified 1,x-diols using stepwise
Grignard homo-coupling
2-[[4-(Chloromethyl)benzyl]oxy]tetrahydro-2H-pyran
(8, C13H17ClO2)
A solution of 5.0 g 7 (32 mmol) and 3.8 g DHP (45 mmol) in
100 cm3 dryCHCl3 wasstirred at25 °C for24 h. Afterwards,
100 cm3 water was added and the organic layer was
separated. The aqueous residue was extracted with 50 cm3
CHCl3 (29). Thecombined organic phaseswerewashed with
50 cm3 water, dried over Na2SO4, evaporated, and the
residue was purified by column chromatography using the
gradient technique and heptane–Et2O and TEA (0.5 %) as
eluent to afford 6.5 g (84 %) of 8 as colourless oil. Rf = 0.44
(solventA);1HNMR(400 MHz,CDCl3):d = 1.46–1.81(m,
6H, –OCH(CH2)3CH2O–), 3.43–3.49 (m, 1H, –OCH(CH2)3-
CH2O–), 3.78–3.86 (m, 1H, –OCH(CH2)3CH2O–), 4.44 (d,
2J = 12.2 Hz, 1H, –OCH2C6H4–), 4.50 (s, 2H, –CH2Cl),
2
4.63–4.64 (m, 1H, –OCHO–), 4.71 (d, J = 12.2 Hz, 1H,
–OCH2C6H4–), 7.29 (s, 4H, –C6H4–) ppm; 13C NMR
(100 MHz, CDCl3): d = 19.27 (CHCH2CH2(CH2)2O–),
25.43 (CH(CH2)2CH2CH2O–), 30.49 (CHCH2(CH2)3O–),
45.92 (ClCH2–), 61.99 (CH(CH2)3CH2O–), 68.25
(–OCH2C6H4–), 97.69 (–OCHO–), 127.88 and 128.44
(2,3,5,6-C, –C6H4–), 136.54 and 138.60 (1,4-C, –C6H4–)
ppm; MS (70 eV): m/z (%) = 240 (14) [M?], 205 (7)
[M?-Cl], 139 (100) [M?-C5H9O2], 104 (59) [M?-
C5H9O2Cl], 91 (15) [C7H7?], 85 (39) [C5H9O?].
1-[16-(Benzyloxy)hexadecyl]-4-(bromomethyl)benzene
(10, C30H45BrO)
A solution of 0.19 cm3 bromine (3.8 mmol), diluted in 5 cm3
CH2Cl2, was added dropwise into a solution of 1.0 g
triphenylphosphane (3.8 mmol) in 10 cm3 dry CH2Cl2 whilst
stirringat 0 °C. A solutionof 0.9 g 9 (1.7 mmol), dissolvedin
3 cm3 CH2Cl2, was added and the mixture was stirred for
16 h at 25 °C. Afterwards, the organic layer was washed with
15 cm3 brine (29), dried over Na2SO4, evaporated, and the
crude product was purified by column chromatography with
heptane as eluent to afford 0.77 g (90 %) of 10 as white
crystalline substance. Rf = 0.53 (solvent A); 1H NMR
(400 MHz, CDCl3): d = 1.23–1.36 (m, 24H, –(CH2)2
(CH2)12(CH2)2O–), 1.54–1.63 (m, 4H, –CH2CH2
(CH2)12CH2CH2O–), 2.57 (t, 3J = 7.8 Hz, 2H, –CH2C6
H4CH2Br), 3.45 (t, 3J = 6.7 Hz, 2H, –CH2OCH2
C6H5), 4.47 (s, 2H, –CH2Br), 4.48 (s, 2H, –OCH2C6H5),
7.12–7.16 (m, 2H, 2,6-H –C6H4–), 7.25–7.29 (m, 2H, 3,5-H,
–C6H4–), 7.32–7.33 (m, 5H, –C6H5) ppm; 13C NMR
(100 MHz, CDCl3): d = 26.20 (–CH2(CH2)2OCH2C6H5),
29.30, 29.31, 29.49, 29.57, 29.60, 29.61, 29.66, 29.67, 29.78
2-[[4-[16-(Benzyloxy)hexadecyl]benzyl]oxy]-
tetrahydro-2H-pyran (9, C32H54O3)
A solution of 2.66 g benzyl 15-bromopentadecyl ether
(6.7 mmol) in 25 cm3 dry THF was added dropwise to
0.24 g magnesium turnings (10 mmol) under argon atmo-
sphere while stirring. Afterwards, the mixture was heated
to 50 °C for 3 h. The excess magnesium was removed
under argon atmosphere and the Grignard solution was
cooled to 0 °C. Then 1.0 cm3 Li2CuCl4 (0.1 M in THF)
was added with stirring followed by a solution of 1.6 g 8
(6.6 mmol) in 10 cm3 dry THF. The stirring was continued
for a further 2 h at 0 °C. For the work-up 100 cm3 Et2O
was added and the resulting mixture was poured into
123